A single-step process designed for the rapid detection of drugs of abuse in human urine. No complex procedures required.
The test is performed using only a human urine sample. No blood draw or special preparation is needed.
Applies a qualitative, competitive lateral flow immunoassay method. Provides visual results for each drug panel.
Capable of detecting substances such as AMP, THC, COC, OPI, MET, and others. Up to 14 drug indicators can be included.